Discontinued — last reported Q2 '25
Business Segments · Operating Income (Loss), Before Adjustments
Life Science Member — Operating Income (Loss), Before Adjustments
STERIS Life Science Member — Operating Income (Loss), Before Adjustments increased by 11.6% to $58.70M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.6%, from $52.60M to $58.70M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ2 2022
Last reportedQ2 2025
How to read this metric
An increase reflects improved operational efficiency or higher margins within the segment's core business activities.
Detailed definition
This metric measures the raw operating profitability of the Life Science segment before any non-recurring or special adj...
Peer comparison
Comparable to unadjusted segment operating profit metrics used by peers to evaluate core business performance.
Metric ID:
ste_segment_life_science_member_operating_income_loss_before_adjustmentsHistorical Data
10 periods
| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.56M | $52.56M | $52.56M | $52.56M | $55.34M | $55.34M | $55.34M | $55.34M | $52.60M | $58.70M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +5.3% | +0.0% | +0.0% | +0.0% | -4.9% | +11.6% |
| YoY Change | — | — | — | — | +5.3% | +5.3% | +5.3% | +5.3% | -4.9% | +11.6% |
Range$52.56M – $58.70M
CAGR+5.0%
Avg YoY Growth+4.6%
Median YoY Growth+5.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is STERIS's life science member — operating income (loss), before adjustments?
- STERIS (STE) reported life science member — operating income (loss), before adjustments of $58.70M in Q2 2025.
- How has STERIS's life science member — operating income (loss), before adjustments changed year-over-year?
- STERIS's life science member — operating income (loss), before adjustments increased by 11.6% year-over-year, from $52.60M to $58.70M.
- What does life science member — operating income (loss), before adjustments mean?
- The unadjusted operating profit or loss generated by the Life Science segment.